Shuting Lu
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 7
- Molecular Medicine top 10%
- Endocrinology top 10%
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 16
- Graphene and Nanomaterials Applications 4
- Materials Chemistry top 10%
- Nanocluster Synthesis and Applications 6
- Carbon and Quantum Dots Applications 6
- Advanced Nanomaterials in Catalysis 5
-
- Ferroptosis and cancer prognosis 3
-
- Extracellular vesicles in disease 3
- Journals
- Biomaterials (4 papers)International Journal of Nanomedicine (3 papers)Biomaterials Science (3 papers)
- Partner nations
- ChinaUnited StatesMaldives
In The Last Decade
Shuting Lu
50 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 131
- Biomaterials 233
- Molecular Medicine 69
- Endocrinology 59
- Biomedical Engineering 455
- Materials Chemistry 402
Countries citing papers authored by Shuting Lu
This map shows the geographic impact of Shuting Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Lu more than expected).
Fields of papers citing papers by Shuting Lu
This network shows the impact of papers produced by Shuting Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Lu. The network helps show where Shuting Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuting Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 40 | |
| 9 | 2022 | 26 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 18 | |
| 13 | 2020 | 31 | |
| 14 | 2020 | 11 | |
| 15 | 2018 | 21 | |
| 16 | 2018 | 26 | |
| 17 | 2017 | 4 | |
| 18 | 2017 | 59 | |
| 19 | 2017 | 106 | |
| 20 | 2012 | 38 |
About Shuting Lu
Shuting Lu is a scholar working on Biomaterials, Biomedical Engineering, Complementary and Manual Therapy, Materials Chemistry and Endocrinology, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (7 papers), Nanocluster Synthesis and Applications (6 papers), Carbon and Quantum Dots Applications (6 papers), Advanced Nanomaterials in Catalysis (5 papers), Graphene and Nanomaterials Applications (4 papers), Ferroptosis and cancer prognosis (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Biomaterials (233 citations), Molecular Medicine (69 citations), Endocrinology (59 citations), Biomedical Engineering (455 citations) and Materials Chemistry (402 citations). Shuting Lu has collaborated with scholars based in China, United States and Maldives. Frequent co-authors include Ting Wang, Bo Wu, Haibo Xu, Tiedong Sun, Shi‐Wen Huang, Xinran Song, Wei Feng, Yu Chen, Wancheng Zhao and Xiaocheng Fan. Their work appears in journals such as Biomaterials, International Journal of Nanomedicine, Biomaterials Science, Advanced Healthcare Materials and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.